pharmaobservatory 0.1.7 → 0.1.9
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +163 -9
- data/docs/AnimalWelfareAssurancesResponse.md +58 -0
- data/docs/{BiomarkerAssayEvidenceResponseBuild.md → AnimalWelfareAssurancesResponseBuild.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseFreshness.md → AnimalWelfareAssurancesResponseFreshness.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseScope.md → AnimalWelfareAssurancesResponseScope.md} +2 -2
- data/docs/AnimalWelfareAssurancesRow.md +48 -0
- data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
- data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
- data/docs/BiomarkerAssayEvidenceResponse.md +3 -3
- data/docs/BiomarkerAssayProvidersResponse.md +58 -0
- data/docs/BiomarkerAssayProvidersRow.md +72 -0
- data/docs/BiomarkerAssayWhitespaceResponse.md +3 -3
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
- data/docs/BiomarkerEvidenceByYearRow.md +32 -0
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerTraversalStatusResponse.md +58 -0
- data/docs/BiomarkerTraversalStatusRow.md +36 -0
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersApi.md +320 -0
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BrandCompaniesResponse.md +3 -3
- data/docs/BrandRevenueResponse.md +3 -3
- data/docs/CatalystsResponse.md +3 -3
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CliaCertificatesResponse.md +3 -3
- data/docs/CompaniesApi.md +2113 -391
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesRecordAttributes.md +2 -0
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
- data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
- data/docs/CompanyCollaboratorsResponse.md +58 -0
- data/docs/CompanyCollaboratorsRow.md +42 -0
- data/docs/CompanyCompetitorActivityResponse.md +58 -0
- data/docs/CompanyCompetitorActivityRow.md +42 -0
- data/docs/CompanyCompetitorsResponse.md +58 -0
- data/docs/CompanyCompetitorsRow.md +66 -0
- data/docs/CompanyFinancialsResponse.md +58 -0
- data/docs/CompanyFinancialsRow.md +108 -0
- data/docs/CompanyFirmographicsResponse.md +58 -0
- data/docs/CompanyFirmographicsRow.md +80 -0
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
- data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTimelineResponse.md +58 -0
- data/docs/CompanyTimelineRow.md +68 -0
- data/docs/CompanyTrialGeographyResponse.md +3 -3
- data/docs/CompanyTrialSitesResponse.md +3 -3
- data/docs/CompanyUsPatentsResponse.md +58 -0
- data/docs/CompanyUsPatentsRow.md +34 -0
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionInvestigatorOrganizationsResponse.md +58 -0
- data/docs/ConditionInvestigatorOrganizationsRow.md +44 -0
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +3 -3
- data/docs/ConditionRecruitmentDurationResponse.md +3 -3
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +3 -3
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionsApi.md +160 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsResponse.md +3 -3
- data/docs/CroFootprintResponse.md +3 -3
- data/docs/CroTrialsResponse.md +3 -3
- data/docs/DebarmentsResponse.md +3 -3
- data/docs/DrugApprovalsResponse.md +3 -3
- data/docs/DrugAspCodesResponse.md +3 -3
- data/docs/DrugBrandsResponse.md +3 -3
- data/docs/DrugCombinationsResponse.md +3 -3
- data/docs/DrugDeclaredPatentsResponse.md +3 -3
- data/docs/DrugInvestigatorsResponse.md +58 -0
- data/docs/DrugInvestigatorsRow.md +32 -0
- data/docs/DrugLabelSafetyResponse.md +3 -3
- data/docs/DrugMedicareSpendResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/DrugPatentMentionsResponse.md +3 -3
- data/docs/DrugPatentOwnersResponse.md +3 -3
- data/docs/DrugPricingResponse.md +3 -3
- data/docs/DrugRecallsResponse.md +3 -3
- data/docs/DrugRegulatoryResponse.md +3 -3
- data/docs/DrugSitesResponse.md +3 -3
- data/docs/DrugTargetsResponse.md +3 -3
- data/docs/DrugTrialConditionsResponse.md +3 -3
- data/docs/DrugTrialsResponse.md +3 -3
- data/docs/DrugVariantsResponse.md +3 -3
- data/docs/DrugsApi.md +80 -0
- data/docs/DrugsRecord.md +2 -2
- data/docs/DrugsResponse.md +3 -3
- data/docs/EnforcementEventsResponse.md +3 -3
- data/docs/EnforcementEventsRow.md +22 -4
- data/docs/GxpFacilitiesResponse.md +3 -3
- data/docs/GxpFacilitiesRow.md +49 -1
- data/docs/HospitalBedsYearlyResponse.md +3 -3
- data/docs/HospitalFacilityChangesResponse.md +3 -3
- data/docs/HospitalsApi.md +80 -0
- data/docs/HospitalsRecord.md +2 -2
- data/docs/HospitalsResponse.md +3 -3
- data/docs/ImportRefusalsResponse.md +3 -3
- data/docs/InspectionFindingsResponse.md +3 -3
- data/docs/InspectionsResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalQuarterTotalsResponse.md +3 -3
- data/docs/InvestigatorConditionsResponse.md +58 -0
- data/docs/InvestigatorConditionsRow.md +28 -0
- data/docs/InvestigatorDebarmentsResponse.md +58 -0
- data/docs/InvestigatorDebarmentsRow.md +32 -0
- data/docs/InvestigatorHospitalsResponse.md +58 -0
- data/docs/InvestigatorHospitalsRow.md +28 -0
- data/docs/InvestigatorInspectionsResponse.md +58 -0
- data/docs/InvestigatorInspectionsRow.md +46 -0
- data/docs/InvestigatorPublicationsResponse.md +58 -0
- data/docs/InvestigatorPublicationsRow.md +34 -0
- data/docs/InvestigatorTopicsResponse.md +58 -0
- data/docs/InvestigatorTopicsRow.md +34 -0
- data/docs/InvestigatorTrialsResponse.md +58 -0
- data/docs/InvestigatorTrialsRow.md +64 -0
- data/docs/InvestigatorsApi.md +1113 -0
- data/docs/InvestigatorsRecord.md +38 -0
- data/docs/InvestigatorsResponse.md +58 -0
- data/docs/InvestigatorsRow.md +70 -0
- data/docs/InvestorFundsResponse.md +3 -3
- data/docs/InvestorPortfolioResponse.md +3 -3
- data/docs/InvestorPrivateFundsResponse.md +3 -3
- data/docs/InvestorsRecord.md +2 -2
- data/docs/InvestorsResponse.md +3 -3
- data/docs/InvestorsRow.md +6 -0
- data/docs/LegalEntitiesApi.md +1401 -281
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesRecordAttributes.md +6 -0
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitySecFilingsResponse.md +58 -0
- data/docs/LegalEntitySecFilingsRow.md +44 -0
- data/docs/ManagersRecord.md +2 -2
- data/docs/ManagersResponse.md +3 -3
- data/docs/OrgDisclosureTrendResponse.md +58 -0
- data/docs/OrgDisclosureTrendRow.md +62 -0
- data/docs/OrgDisclosuresResponse.md +3 -3
- data/docs/OrgRelationshipsResponse.md +3 -3
- data/docs/OwnershipObservationsResponse.md +58 -0
- data/docs/OwnershipObservationsRow.md +168 -0
- data/docs/OwnershipPercentagesResponse.md +3 -3
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipSourceCoverageResponse.md +58 -0
- data/docs/OwnershipSourceCoverageRow.md +62 -0
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesResponse.md +3 -3
- data/docs/ProgramsResponse.md +3 -3
- data/docs/RareDiseaseGenesResponse.md +3 -3
- data/docs/RareDiseaseHierarchyResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorsResponse.md +3 -3
- data/docs/RareDiseaseMappingsResponse.md +3 -3
- data/docs/RareDiseaseOrganizationsResponse.md +3 -3
- data/docs/RareDiseasePrevalenceResponse.md +3 -3
- data/docs/RareDiseaseRarityEvidenceResponse.md +3 -3
- data/docs/RareDiseaseRarityResponse.md +3 -3
- data/docs/RareDiseaseReplacementsResponse.md +3 -3
- data/docs/RareDiseaseSiteCoverageResponse.md +3 -3
- data/docs/RareDiseaseSponsorsResponse.md +3 -3
- data/docs/RareDiseaseTrialCoverageResponse.md +3 -3
- data/docs/RareDiseaseTrialSitesResponse.md +3 -3
- data/docs/RareDiseaseTrialsResponse.md +3 -3
- data/docs/RareDiseasesRecord.md +2 -2
- data/docs/RareDiseasesResponse.md +3 -3
- data/docs/RecallsResponse.md +3 -3
- data/docs/RwdConductorDeliveryResponse.md +58 -0
- data/docs/RwdConductorDeliveryRow.md +74 -0
- data/docs/RwdConductorFootprintResponse.md +58 -0
- data/docs/RwdConductorFootprintRow.md +40 -0
- data/docs/RwdConductorStudiesResponse.md +58 -0
- data/docs/RwdConductorStudiesRow.md +42 -0
- data/docs/RwdConductorsApi.md +393 -0
- data/docs/RwdConductorsRecord.md +38 -0
- data/docs/RwdConductorsResponse.md +58 -0
- data/docs/RwdConductorsRow.md +72 -0
- data/docs/RwdCoverageResponse.md +3 -3
- data/docs/RwdInstitutionsApi.md +153 -0
- data/docs/RwdInstitutionsRecord.md +38 -0
- data/docs/RwdInstitutionsResponse.md +58 -0
- data/docs/RwdInstitutionsRow.md +154 -0
- data/docs/RwdNetworksApi.md +153 -0
- data/docs/RwdNetworksRecord.md +38 -0
- data/docs/RwdNetworksResponse.md +58 -0
- data/docs/RwdNetworksRow.md +110 -0
- data/docs/RwdRegisterProvenanceResponse.md +3 -3
- data/docs/RwdRegistersRecord.md +2 -2
- data/docs/RwdSourceAgeBandsResponse.md +3 -3
- data/docs/RwdSourceConditionsResponse.md +3 -3
- data/docs/RwdSourceEtlMappingsResponse.md +3 -3
- data/docs/RwdSourceLinkagesResponse.md +3 -3
- data/docs/RwdSourceTypesResponse.md +3 -3
- data/docs/RwdSourceVocabulariesResponse.md +3 -3
- data/docs/RwdSourcesRecord.md +2 -2
- data/docs/RwdSourcesResponse.md +3 -3
- data/docs/RwdStudiesApi.md +80 -0
- data/docs/RwdStudiesRecord.md +2 -2
- data/docs/RwdStudiesResponse.md +3 -3
- data/docs/RwdStudyConditionsResponse.md +3 -3
- data/docs/RwdStudyDataSourcesResponse.md +3 -3
- data/docs/RwdStudyDrugsResponse.md +3 -3
- data/docs/RwdStudyMilestonesResponse.md +3 -3
- data/docs/RwdWithheldFieldsResponse.md +3 -3
- data/docs/SbtiCrosscheckResponse.md +58 -0
- data/docs/SbtiCrosscheckRow.md +48 -0
- data/docs/SecPdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorDeliveryResponse.md +58 -0
- data/docs/SponsorDeliveryRow.md +52 -0
- data/docs/SponsorPatentMentionsResponse.md +58 -0
- data/docs/SponsorPatentMentionsRow.md +42 -0
- data/docs/SponsorPublicationsResponse.md +58 -0
- data/docs/SponsorPublicationsRow.md +42 -0
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialConditionsResponse.md +58 -0
- data/docs/SponsorTrialConditionsRow.md +36 -0
- data/docs/SponsorTrialDrugsResponse.md +58 -0
- data/docs/SponsorTrialDrugsRow.md +34 -0
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SupplierCapabilityEsgResponse.md +3 -3
- data/docs/SupplierServicesResponse.md +3 -3
- data/docs/SupplierSitesResponse.md +3 -3
- data/docs/SuppliersRecord.md +2 -2
- data/docs/SuppliersResponse.md +3 -3
- data/docs/SuppliersRow.md +2 -0
- data/docs/TargetAssociationsResponse.md +3 -3
- data/docs/TargetCrowdingResponse.md +3 -3
- data/docs/TargetDrugsResponse.md +3 -3
- data/docs/TargetEvidenceResponse.md +3 -3
- data/docs/TargetInvestigatorsResponse.md +58 -0
- data/docs/TargetInvestigatorsRow.md +30 -0
- data/docs/TargetPatentMentionsResponse.md +3 -3
- data/docs/TargetProgramsResponse.md +3 -3
- data/docs/TargetPublicationsResponse.md +3 -3
- data/docs/TargetRegulatoryPrecedentResponse.md +3 -3
- data/docs/TargetTrialsResponse.md +3 -3
- data/docs/TargetsApi.md +80 -0
- data/docs/TargetsRecord.md +2 -2
- data/docs/TargetsResponse.md +3 -3
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +3 -3
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +3 -3
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +3 -3
- data/docs/TrialSiteHistoryResponse.md +3 -3
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/docs/UnmatchedProductRevenueResponse.md +3 -3
- data/docs/UntitledLettersResponse.md +3 -3
- data/docs/WarningLettersResponse.md +3 -3
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +2360 -449
- data/lib/pharmaobservatory/api/conditions_api.rb +168 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +84 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +84 -0
- data/lib/pharmaobservatory/api/investigators_api.rb +1169 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +1460 -284
- data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
- data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_studies_api.rb +84 -0
- data/lib/pharmaobservatory/api/targets_api.rb +84 -0
- data/lib/pharmaobservatory/models/animal_welfare_assurances_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_build.rb → animal_welfare_assurances_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_freshness.rb → animal_welfare_assurances_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_scope.rb → animal_welfare_assurances_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/animal_welfare_assurances_row.rb +392 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/catalysts_response.rb +3 -3
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +10 -1
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_collaborators_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_collaborators_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitors_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitors_row.rb +493 -0
- data/lib/pharmaobservatory/models/company_financials_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_financials_row.rb +718 -0
- data/lib/pharmaobservatory/models/company_firmographics_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_firmographics_row.rb +566 -0
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_timeline_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_timeline_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_us_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_us_patents_row.rb +311 -0
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_investigator_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_investigator_organizations_row.rb +366 -0
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/debarments_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_brands_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_investigators_row.rb +302 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_variants_response.rb +3 -3
- data/lib/pharmaobservatory/models/drugs_record.rb +2 -2
- data/lib/pharmaobservatory/models/drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +104 -5
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +3 -3
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +266 -2
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospitals_record.rb +2 -2
- data/lib/pharmaobservatory/models/hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/import_refusals_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspections_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +3 -3
- data/lib/pharmaobservatory/models/investigator_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_conditions_row.rb +278 -0
- data/lib/pharmaobservatory/models/investigator_debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_debarments_row.rb +300 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_row.rb +280 -0
- data/lib/pharmaobservatory/models/investigator_inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_inspections_row.rb +377 -0
- data/lib/pharmaobservatory/models/investigator_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_publications_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_topics_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_topics_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_trials_row.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_record.rb +385 -0
- data/lib/pharmaobservatory/models/investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_row.rb +511 -0
- data/lib/pharmaobservatory/models/investor_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_record.rb +2 -2
- data/lib/pharmaobservatory/models/investors_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_row.rb +34 -1
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +28 -1
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
- data/lib/pharmaobservatory/models/managers_record.rb +2 -2
- data/lib/pharmaobservatory/models/managers_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_relationships_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_observations_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_observations_row.rb +1048 -0
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +3 -3
- data/lib/pharmaobservatory/models/programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +2 -2
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +3 -3
- data/lib/pharmaobservatory/models/recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +3 -3
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_publications_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_services_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_record.rb +2 -2
- data/lib/pharmaobservatory/models/suppliers_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_row.rb +12 -1
- data/lib/pharmaobservatory/models/target_associations_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_crowding_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_investigators_row.rb +291 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/targets_record.rb +2 -2
- data/lib/pharmaobservatory/models/targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +3 -3
- data/lib/pharmaobservatory/models/warning_letters_response.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +93 -3
- metadata +188 -8
metadata
CHANGED
|
@@ -1,14 +1,14 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.9
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
8
8
|
autorequire:
|
|
9
9
|
bindir: bin
|
|
10
10
|
cert_chain: []
|
|
11
|
-
date: 2026-10-
|
|
11
|
+
date: 2026-10-24 00:00:00.000000000 Z
|
|
12
12
|
dependencies:
|
|
13
13
|
- !ruby/object:Gem::Dependency
|
|
14
14
|
name: faraday
|
|
@@ -87,6 +87,11 @@ extensions: []
|
|
|
87
87
|
extra_rdoc_files: []
|
|
88
88
|
files:
|
|
89
89
|
- README.md
|
|
90
|
+
- docs/AnimalWelfareAssurancesResponse.md
|
|
91
|
+
- docs/AnimalWelfareAssurancesResponseBuild.md
|
|
92
|
+
- docs/AnimalWelfareAssurancesResponseFreshness.md
|
|
93
|
+
- docs/AnimalWelfareAssurancesResponseScope.md
|
|
94
|
+
- docs/AnimalWelfareAssurancesRow.md
|
|
90
95
|
- docs/ApiV1BaseApi.md
|
|
91
96
|
- docs/ApiV1WhoamiGet200Response.md
|
|
92
97
|
- docs/ApiV1WhoamiGet200ResponseLimits.md
|
|
@@ -94,17 +99,20 @@ files:
|
|
|
94
99
|
- docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md
|
|
95
100
|
- docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md
|
|
96
101
|
- docs/AuthError.md
|
|
102
|
+
- docs/BiomarkerAlleleFrequenciesResponse.md
|
|
103
|
+
- docs/BiomarkerAlleleFrequenciesRow.md
|
|
97
104
|
- docs/BiomarkerAssayEvidenceResponse.md
|
|
98
|
-
- docs/BiomarkerAssayEvidenceResponseBuild.md
|
|
99
|
-
- docs/BiomarkerAssayEvidenceResponseFreshness.md
|
|
100
|
-
- docs/BiomarkerAssayEvidenceResponseScope.md
|
|
101
105
|
- docs/BiomarkerAssayEvidenceRow.md
|
|
106
|
+
- docs/BiomarkerAssayProvidersResponse.md
|
|
107
|
+
- docs/BiomarkerAssayProvidersRow.md
|
|
102
108
|
- docs/BiomarkerAssayWhitespaceResponse.md
|
|
103
109
|
- docs/BiomarkerAssayWhitespaceRow.md
|
|
104
110
|
- docs/BiomarkerBqpAssertionsResponse.md
|
|
105
111
|
- docs/BiomarkerBqpAssertionsRow.md
|
|
106
112
|
- docs/BiomarkerCdxAssertionsResponse.md
|
|
107
113
|
- docs/BiomarkerCdxAssertionsRow.md
|
|
114
|
+
- docs/BiomarkerEvidenceByYearResponse.md
|
|
115
|
+
- docs/BiomarkerEvidenceByYearRow.md
|
|
108
116
|
- docs/BiomarkerEvidenceResponse.md
|
|
109
117
|
- docs/BiomarkerEvidenceRow.md
|
|
110
118
|
- docs/BiomarkerLiteratureResponse.md
|
|
@@ -117,6 +125,8 @@ files:
|
|
|
117
125
|
- docs/BiomarkerSampleCoverageRow.md
|
|
118
126
|
- docs/BiomarkerSamplePrevalenceResponse.md
|
|
119
127
|
- docs/BiomarkerSamplePrevalenceRow.md
|
|
128
|
+
- docs/BiomarkerTraversalStatusResponse.md
|
|
129
|
+
- docs/BiomarkerTraversalStatusRow.md
|
|
120
130
|
- docs/BiomarkerValidationResponse.md
|
|
121
131
|
- docs/BiomarkerValidationRow.md
|
|
122
132
|
- docs/BiomarkerVariantMentionsResponse.md
|
|
@@ -144,6 +154,18 @@ files:
|
|
|
144
154
|
- docs/CompaniesRow.md
|
|
145
155
|
- docs/CompanyAssetsResponse.md
|
|
146
156
|
- docs/CompanyAssetsRow.md
|
|
157
|
+
- docs/CompanyBiomarkerCapabilityResponse.md
|
|
158
|
+
- docs/CompanyBiomarkerCapabilityRow.md
|
|
159
|
+
- docs/CompanyCollaboratorsResponse.md
|
|
160
|
+
- docs/CompanyCollaboratorsRow.md
|
|
161
|
+
- docs/CompanyCompetitorActivityResponse.md
|
|
162
|
+
- docs/CompanyCompetitorActivityRow.md
|
|
163
|
+
- docs/CompanyCompetitorsResponse.md
|
|
164
|
+
- docs/CompanyCompetitorsRow.md
|
|
165
|
+
- docs/CompanyFinancialsResponse.md
|
|
166
|
+
- docs/CompanyFinancialsRow.md
|
|
167
|
+
- docs/CompanyFirmographicsResponse.md
|
|
168
|
+
- docs/CompanyFirmographicsRow.md
|
|
147
169
|
- docs/CompanyFundingEventsResponse.md
|
|
148
170
|
- docs/CompanyFundingEventsRow.md
|
|
149
171
|
- docs/CompanyFundingSummaryResponse.md
|
|
@@ -152,12 +174,18 @@ files:
|
|
|
152
174
|
- docs/CompanyMembersRow.md
|
|
153
175
|
- docs/CompanyProgramsResponse.md
|
|
154
176
|
- docs/CompanyProgramsRow.md
|
|
177
|
+
- docs/CompanyRareDiseaseDeclarationsResponse.md
|
|
178
|
+
- docs/CompanyRareDiseaseDeclarationsRow.md
|
|
155
179
|
- docs/CompanyTargetsResponse.md
|
|
156
180
|
- docs/CompanyTargetsRow.md
|
|
181
|
+
- docs/CompanyTimelineResponse.md
|
|
182
|
+
- docs/CompanyTimelineRow.md
|
|
157
183
|
- docs/CompanyTrialGeographyResponse.md
|
|
158
184
|
- docs/CompanyTrialGeographyRow.md
|
|
159
185
|
- docs/CompanyTrialSitesResponse.md
|
|
160
186
|
- docs/CompanyTrialSitesRow.md
|
|
187
|
+
- docs/CompanyUsPatentsResponse.md
|
|
188
|
+
- docs/CompanyUsPatentsRow.md
|
|
161
189
|
- docs/ConditionAdverseEventsResponse.md
|
|
162
190
|
- docs/ConditionAdverseEventsRow.md
|
|
163
191
|
- docs/ConditionBurdenResponse.md
|
|
@@ -166,6 +194,8 @@ files:
|
|
|
166
194
|
- docs/ConditionDeliveryRow.md
|
|
167
195
|
- docs/ConditionDrugsResponse.md
|
|
168
196
|
- docs/ConditionDrugsRow.md
|
|
197
|
+
- docs/ConditionInvestigatorOrganizationsResponse.md
|
|
198
|
+
- docs/ConditionInvestigatorOrganizationsRow.md
|
|
169
199
|
- docs/ConditionPrevalenceResponse.md
|
|
170
200
|
- docs/ConditionPrevalenceRow.md
|
|
171
201
|
- docs/ConditionPublicationsResponse.md
|
|
@@ -208,6 +238,8 @@ files:
|
|
|
208
238
|
- docs/DrugCombinationsRow.md
|
|
209
239
|
- docs/DrugDeclaredPatentsResponse.md
|
|
210
240
|
- docs/DrugDeclaredPatentsRow.md
|
|
241
|
+
- docs/DrugInvestigatorsResponse.md
|
|
242
|
+
- docs/DrugInvestigatorsRow.md
|
|
211
243
|
- docs/DrugLabelSafetyResponse.md
|
|
212
244
|
- docs/DrugLabelSafetyRow.md
|
|
213
245
|
- docs/DrugMedicareSpendResponse.md
|
|
@@ -261,6 +293,24 @@ files:
|
|
|
261
293
|
- docs/InstitutionalHoldingsRow.md
|
|
262
294
|
- docs/InstitutionalQuarterTotalsResponse.md
|
|
263
295
|
- docs/InstitutionalQuarterTotalsRow.md
|
|
296
|
+
- docs/InvestigatorConditionsResponse.md
|
|
297
|
+
- docs/InvestigatorConditionsRow.md
|
|
298
|
+
- docs/InvestigatorDebarmentsResponse.md
|
|
299
|
+
- docs/InvestigatorDebarmentsRow.md
|
|
300
|
+
- docs/InvestigatorHospitalsResponse.md
|
|
301
|
+
- docs/InvestigatorHospitalsRow.md
|
|
302
|
+
- docs/InvestigatorInspectionsResponse.md
|
|
303
|
+
- docs/InvestigatorInspectionsRow.md
|
|
304
|
+
- docs/InvestigatorPublicationsResponse.md
|
|
305
|
+
- docs/InvestigatorPublicationsRow.md
|
|
306
|
+
- docs/InvestigatorTopicsResponse.md
|
|
307
|
+
- docs/InvestigatorTopicsRow.md
|
|
308
|
+
- docs/InvestigatorTrialsResponse.md
|
|
309
|
+
- docs/InvestigatorTrialsRow.md
|
|
310
|
+
- docs/InvestigatorsApi.md
|
|
311
|
+
- docs/InvestigatorsRecord.md
|
|
312
|
+
- docs/InvestigatorsResponse.md
|
|
313
|
+
- docs/InvestigatorsRow.md
|
|
264
314
|
- docs/InvestorFundsResponse.md
|
|
265
315
|
- docs/InvestorFundsRow.md
|
|
266
316
|
- docs/InvestorPortfolioResponse.md
|
|
@@ -276,18 +326,26 @@ files:
|
|
|
276
326
|
- docs/LegalEntitiesRecordAttributes.md
|
|
277
327
|
- docs/LegalEntitiesResponse.md
|
|
278
328
|
- docs/LegalEntitiesRow.md
|
|
329
|
+
- docs/LegalEntitySecFilingsResponse.md
|
|
330
|
+
- docs/LegalEntitySecFilingsRow.md
|
|
279
331
|
- docs/ManagersApi.md
|
|
280
332
|
- docs/ManagersRecord.md
|
|
281
333
|
- docs/ManagersResponse.md
|
|
282
334
|
- docs/ManagersRow.md
|
|
335
|
+
- docs/OrgDisclosureTrendResponse.md
|
|
336
|
+
- docs/OrgDisclosureTrendRow.md
|
|
283
337
|
- docs/OrgDisclosuresResponse.md
|
|
284
338
|
- docs/OrgDisclosuresRow.md
|
|
285
339
|
- docs/OrgRelationshipsResponse.md
|
|
286
340
|
- docs/OrgRelationshipsRow.md
|
|
341
|
+
- docs/OwnershipObservationsResponse.md
|
|
342
|
+
- docs/OwnershipObservationsRow.md
|
|
287
343
|
- docs/OwnershipPercentagesResponse.md
|
|
288
344
|
- docs/OwnershipPercentagesRow.md
|
|
289
345
|
- docs/OwnershipPositionsResponse.md
|
|
290
346
|
- docs/OwnershipPositionsRow.md
|
|
347
|
+
- docs/OwnershipSourceCoverageResponse.md
|
|
348
|
+
- docs/OwnershipSourceCoverageRow.md
|
|
291
349
|
- docs/PdufaDatesResponse.md
|
|
292
350
|
- docs/PdufaDatesRow.md
|
|
293
351
|
- docs/ProgramLicensingCandidatesResponse.md
|
|
@@ -337,8 +395,26 @@ files:
|
|
|
337
395
|
- docs/RecallsResponse.md
|
|
338
396
|
- docs/RecallsRow.md
|
|
339
397
|
- docs/ResultPage.md
|
|
398
|
+
- docs/RwdConductorDeliveryResponse.md
|
|
399
|
+
- docs/RwdConductorDeliveryRow.md
|
|
400
|
+
- docs/RwdConductorFootprintResponse.md
|
|
401
|
+
- docs/RwdConductorFootprintRow.md
|
|
402
|
+
- docs/RwdConductorStudiesResponse.md
|
|
403
|
+
- docs/RwdConductorStudiesRow.md
|
|
404
|
+
- docs/RwdConductorsApi.md
|
|
405
|
+
- docs/RwdConductorsRecord.md
|
|
406
|
+
- docs/RwdConductorsResponse.md
|
|
407
|
+
- docs/RwdConductorsRow.md
|
|
340
408
|
- docs/RwdCoverageResponse.md
|
|
341
409
|
- docs/RwdCoverageRow.md
|
|
410
|
+
- docs/RwdInstitutionsApi.md
|
|
411
|
+
- docs/RwdInstitutionsRecord.md
|
|
412
|
+
- docs/RwdInstitutionsResponse.md
|
|
413
|
+
- docs/RwdInstitutionsRow.md
|
|
414
|
+
- docs/RwdNetworksApi.md
|
|
415
|
+
- docs/RwdNetworksRecord.md
|
|
416
|
+
- docs/RwdNetworksResponse.md
|
|
417
|
+
- docs/RwdNetworksRow.md
|
|
342
418
|
- docs/RwdRegisterProvenanceResponse.md
|
|
343
419
|
- docs/RwdRegisterProvenanceRow.md
|
|
344
420
|
- docs/RwdRegistersApi.md
|
|
@@ -373,6 +449,8 @@ files:
|
|
|
373
449
|
- docs/RwdStudyMilestonesRow.md
|
|
374
450
|
- docs/RwdWithheldFieldsResponse.md
|
|
375
451
|
- docs/RwdWithheldFieldsRow.md
|
|
452
|
+
- docs/SbtiCrosscheckResponse.md
|
|
453
|
+
- docs/SbtiCrosscheckRow.md
|
|
376
454
|
- docs/SecPdufaDatesResponse.md
|
|
377
455
|
- docs/SecPdufaDatesRow.md
|
|
378
456
|
- docs/SiteBedsYearlyResponse.md
|
|
@@ -394,10 +472,20 @@ files:
|
|
|
394
472
|
- docs/SitesRecordAttributes.md
|
|
395
473
|
- docs/SitesResponse.md
|
|
396
474
|
- docs/SitesRow.md
|
|
475
|
+
- docs/SponsorDeliveryResponse.md
|
|
476
|
+
- docs/SponsorDeliveryRow.md
|
|
477
|
+
- docs/SponsorPatentMentionsResponse.md
|
|
478
|
+
- docs/SponsorPatentMentionsRow.md
|
|
479
|
+
- docs/SponsorPublicationsResponse.md
|
|
480
|
+
- docs/SponsorPublicationsRow.md
|
|
397
481
|
- docs/SponsorRecruitmentByPhaseResponse.md
|
|
398
482
|
- docs/SponsorRecruitmentByPhaseRow.md
|
|
399
483
|
- docs/SponsorRecruitmentDurationResponse.md
|
|
400
484
|
- docs/SponsorRecruitmentDurationRow.md
|
|
485
|
+
- docs/SponsorTrialConditionsResponse.md
|
|
486
|
+
- docs/SponsorTrialConditionsRow.md
|
|
487
|
+
- docs/SponsorTrialDrugsResponse.md
|
|
488
|
+
- docs/SponsorTrialDrugsRow.md
|
|
401
489
|
- docs/SponsorTrialStartForecastResponse.md
|
|
402
490
|
- docs/SponsorTrialStartForecastRow.md
|
|
403
491
|
- docs/SponsorTrialsResponse.md
|
|
@@ -420,6 +508,8 @@ files:
|
|
|
420
508
|
- docs/TargetDrugsRow.md
|
|
421
509
|
- docs/TargetEvidenceResponse.md
|
|
422
510
|
- docs/TargetEvidenceRow.md
|
|
511
|
+
- docs/TargetInvestigatorsResponse.md
|
|
512
|
+
- docs/TargetInvestigatorsRow.md
|
|
423
513
|
- docs/TargetPatentMentionsResponse.md
|
|
424
514
|
- docs/TargetPatentMentionsRow.md
|
|
425
515
|
- docs/TargetProgramsResponse.md
|
|
@@ -482,11 +572,15 @@ files:
|
|
|
482
572
|
- lib/pharmaobservatory/api/datasets_api.rb
|
|
483
573
|
- lib/pharmaobservatory/api/drugs_api.rb
|
|
484
574
|
- lib/pharmaobservatory/api/hospitals_api.rb
|
|
575
|
+
- lib/pharmaobservatory/api/investigators_api.rb
|
|
485
576
|
- lib/pharmaobservatory/api/investors_api.rb
|
|
486
577
|
- lib/pharmaobservatory/api/legal_entities_api.rb
|
|
487
578
|
- lib/pharmaobservatory/api/managers_api.rb
|
|
488
579
|
- lib/pharmaobservatory/api/query_api.rb
|
|
489
580
|
- lib/pharmaobservatory/api/rare_diseases_api.rb
|
|
581
|
+
- lib/pharmaobservatory/api/rwd_conductors_api.rb
|
|
582
|
+
- lib/pharmaobservatory/api/rwd_institutions_api.rb
|
|
583
|
+
- lib/pharmaobservatory/api/rwd_networks_api.rb
|
|
490
584
|
- lib/pharmaobservatory/api/rwd_registers_api.rb
|
|
491
585
|
- lib/pharmaobservatory/api/rwd_sources_api.rb
|
|
492
586
|
- lib/pharmaobservatory/api/rwd_studies_api.rb
|
|
@@ -497,23 +591,31 @@ files:
|
|
|
497
591
|
- lib/pharmaobservatory/api_client.rb
|
|
498
592
|
- lib/pharmaobservatory/api_error.rb
|
|
499
593
|
- lib/pharmaobservatory/configuration.rb
|
|
594
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response.rb
|
|
595
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_build.rb
|
|
596
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_freshness.rb
|
|
597
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_scope.rb
|
|
598
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_row.rb
|
|
500
599
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb
|
|
501
600
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb
|
|
502
601
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb
|
|
503
602
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb
|
|
504
603
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb
|
|
505
604
|
- lib/pharmaobservatory/models/auth_error.rb
|
|
605
|
+
- lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb
|
|
606
|
+
- lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb
|
|
506
607
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb
|
|
507
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_build.rb
|
|
508
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_freshness.rb
|
|
509
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_scope.rb
|
|
510
608
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb
|
|
609
|
+
- lib/pharmaobservatory/models/biomarker_assay_providers_response.rb
|
|
610
|
+
- lib/pharmaobservatory/models/biomarker_assay_providers_row.rb
|
|
511
611
|
- lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb
|
|
512
612
|
- lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb
|
|
513
613
|
- lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb
|
|
514
614
|
- lib/pharmaobservatory/models/biomarker_bqp_assertions_row.rb
|
|
515
615
|
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb
|
|
516
616
|
- lib/pharmaobservatory/models/biomarker_cdx_assertions_row.rb
|
|
617
|
+
- lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb
|
|
618
|
+
- lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb
|
|
517
619
|
- lib/pharmaobservatory/models/biomarker_evidence_response.rb
|
|
518
620
|
- lib/pharmaobservatory/models/biomarker_evidence_row.rb
|
|
519
621
|
- lib/pharmaobservatory/models/biomarker_literature_response.rb
|
|
@@ -526,6 +628,8 @@ files:
|
|
|
526
628
|
- lib/pharmaobservatory/models/biomarker_sample_coverage_row.rb
|
|
527
629
|
- lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb
|
|
528
630
|
- lib/pharmaobservatory/models/biomarker_sample_prevalence_row.rb
|
|
631
|
+
- lib/pharmaobservatory/models/biomarker_traversal_status_response.rb
|
|
632
|
+
- lib/pharmaobservatory/models/biomarker_traversal_status_row.rb
|
|
529
633
|
- lib/pharmaobservatory/models/biomarker_validation_response.rb
|
|
530
634
|
- lib/pharmaobservatory/models/biomarker_validation_row.rb
|
|
531
635
|
- lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb
|
|
@@ -550,6 +654,18 @@ files:
|
|
|
550
654
|
- lib/pharmaobservatory/models/companies_row.rb
|
|
551
655
|
- lib/pharmaobservatory/models/company_assets_response.rb
|
|
552
656
|
- lib/pharmaobservatory/models/company_assets_row.rb
|
|
657
|
+
- lib/pharmaobservatory/models/company_biomarker_capability_response.rb
|
|
658
|
+
- lib/pharmaobservatory/models/company_biomarker_capability_row.rb
|
|
659
|
+
- lib/pharmaobservatory/models/company_collaborators_response.rb
|
|
660
|
+
- lib/pharmaobservatory/models/company_collaborators_row.rb
|
|
661
|
+
- lib/pharmaobservatory/models/company_competitor_activity_response.rb
|
|
662
|
+
- lib/pharmaobservatory/models/company_competitor_activity_row.rb
|
|
663
|
+
- lib/pharmaobservatory/models/company_competitors_response.rb
|
|
664
|
+
- lib/pharmaobservatory/models/company_competitors_row.rb
|
|
665
|
+
- lib/pharmaobservatory/models/company_financials_response.rb
|
|
666
|
+
- lib/pharmaobservatory/models/company_financials_row.rb
|
|
667
|
+
- lib/pharmaobservatory/models/company_firmographics_response.rb
|
|
668
|
+
- lib/pharmaobservatory/models/company_firmographics_row.rb
|
|
553
669
|
- lib/pharmaobservatory/models/company_funding_events_response.rb
|
|
554
670
|
- lib/pharmaobservatory/models/company_funding_events_row.rb
|
|
555
671
|
- lib/pharmaobservatory/models/company_funding_summary_response.rb
|
|
@@ -558,12 +674,18 @@ files:
|
|
|
558
674
|
- lib/pharmaobservatory/models/company_members_row.rb
|
|
559
675
|
- lib/pharmaobservatory/models/company_programs_response.rb
|
|
560
676
|
- lib/pharmaobservatory/models/company_programs_row.rb
|
|
677
|
+
- lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb
|
|
678
|
+
- lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb
|
|
561
679
|
- lib/pharmaobservatory/models/company_targets_response.rb
|
|
562
680
|
- lib/pharmaobservatory/models/company_targets_row.rb
|
|
681
|
+
- lib/pharmaobservatory/models/company_timeline_response.rb
|
|
682
|
+
- lib/pharmaobservatory/models/company_timeline_row.rb
|
|
563
683
|
- lib/pharmaobservatory/models/company_trial_geography_response.rb
|
|
564
684
|
- lib/pharmaobservatory/models/company_trial_geography_row.rb
|
|
565
685
|
- lib/pharmaobservatory/models/company_trial_sites_response.rb
|
|
566
686
|
- lib/pharmaobservatory/models/company_trial_sites_row.rb
|
|
687
|
+
- lib/pharmaobservatory/models/company_us_patents_response.rb
|
|
688
|
+
- lib/pharmaobservatory/models/company_us_patents_row.rb
|
|
567
689
|
- lib/pharmaobservatory/models/condition_adverse_events_response.rb
|
|
568
690
|
- lib/pharmaobservatory/models/condition_adverse_events_row.rb
|
|
569
691
|
- lib/pharmaobservatory/models/condition_burden_response.rb
|
|
@@ -572,6 +694,8 @@ files:
|
|
|
572
694
|
- lib/pharmaobservatory/models/condition_delivery_row.rb
|
|
573
695
|
- lib/pharmaobservatory/models/condition_drugs_response.rb
|
|
574
696
|
- lib/pharmaobservatory/models/condition_drugs_row.rb
|
|
697
|
+
- lib/pharmaobservatory/models/condition_investigator_organizations_response.rb
|
|
698
|
+
- lib/pharmaobservatory/models/condition_investigator_organizations_row.rb
|
|
575
699
|
- lib/pharmaobservatory/models/condition_prevalence_response.rb
|
|
576
700
|
- lib/pharmaobservatory/models/condition_prevalence_row.rb
|
|
577
701
|
- lib/pharmaobservatory/models/condition_publications_response.rb
|
|
@@ -612,6 +736,8 @@ files:
|
|
|
612
736
|
- lib/pharmaobservatory/models/drug_combinations_row.rb
|
|
613
737
|
- lib/pharmaobservatory/models/drug_declared_patents_response.rb
|
|
614
738
|
- lib/pharmaobservatory/models/drug_declared_patents_row.rb
|
|
739
|
+
- lib/pharmaobservatory/models/drug_investigators_response.rb
|
|
740
|
+
- lib/pharmaobservatory/models/drug_investigators_row.rb
|
|
615
741
|
- lib/pharmaobservatory/models/drug_label_safety_response.rb
|
|
616
742
|
- lib/pharmaobservatory/models/drug_label_safety_row.rb
|
|
617
743
|
- lib/pharmaobservatory/models/drug_medicare_spend_response.rb
|
|
@@ -663,6 +789,23 @@ files:
|
|
|
663
789
|
- lib/pharmaobservatory/models/institutional_holdings_row.rb
|
|
664
790
|
- lib/pharmaobservatory/models/institutional_quarter_totals_response.rb
|
|
665
791
|
- lib/pharmaobservatory/models/institutional_quarter_totals_row.rb
|
|
792
|
+
- lib/pharmaobservatory/models/investigator_conditions_response.rb
|
|
793
|
+
- lib/pharmaobservatory/models/investigator_conditions_row.rb
|
|
794
|
+
- lib/pharmaobservatory/models/investigator_debarments_response.rb
|
|
795
|
+
- lib/pharmaobservatory/models/investigator_debarments_row.rb
|
|
796
|
+
- lib/pharmaobservatory/models/investigator_hospitals_response.rb
|
|
797
|
+
- lib/pharmaobservatory/models/investigator_hospitals_row.rb
|
|
798
|
+
- lib/pharmaobservatory/models/investigator_inspections_response.rb
|
|
799
|
+
- lib/pharmaobservatory/models/investigator_inspections_row.rb
|
|
800
|
+
- lib/pharmaobservatory/models/investigator_publications_response.rb
|
|
801
|
+
- lib/pharmaobservatory/models/investigator_publications_row.rb
|
|
802
|
+
- lib/pharmaobservatory/models/investigator_topics_response.rb
|
|
803
|
+
- lib/pharmaobservatory/models/investigator_topics_row.rb
|
|
804
|
+
- lib/pharmaobservatory/models/investigator_trials_response.rb
|
|
805
|
+
- lib/pharmaobservatory/models/investigator_trials_row.rb
|
|
806
|
+
- lib/pharmaobservatory/models/investigators_record.rb
|
|
807
|
+
- lib/pharmaobservatory/models/investigators_response.rb
|
|
808
|
+
- lib/pharmaobservatory/models/investigators_row.rb
|
|
666
809
|
- lib/pharmaobservatory/models/investor_funds_response.rb
|
|
667
810
|
- lib/pharmaobservatory/models/investor_funds_row.rb
|
|
668
811
|
- lib/pharmaobservatory/models/investor_portfolio_response.rb
|
|
@@ -676,17 +819,25 @@ files:
|
|
|
676
819
|
- lib/pharmaobservatory/models/legal_entities_record_attributes.rb
|
|
677
820
|
- lib/pharmaobservatory/models/legal_entities_response.rb
|
|
678
821
|
- lib/pharmaobservatory/models/legal_entities_row.rb
|
|
822
|
+
- lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb
|
|
823
|
+
- lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb
|
|
679
824
|
- lib/pharmaobservatory/models/managers_record.rb
|
|
680
825
|
- lib/pharmaobservatory/models/managers_response.rb
|
|
681
826
|
- lib/pharmaobservatory/models/managers_row.rb
|
|
827
|
+
- lib/pharmaobservatory/models/org_disclosure_trend_response.rb
|
|
828
|
+
- lib/pharmaobservatory/models/org_disclosure_trend_row.rb
|
|
682
829
|
- lib/pharmaobservatory/models/org_disclosures_response.rb
|
|
683
830
|
- lib/pharmaobservatory/models/org_disclosures_row.rb
|
|
684
831
|
- lib/pharmaobservatory/models/org_relationships_response.rb
|
|
685
832
|
- lib/pharmaobservatory/models/org_relationships_row.rb
|
|
833
|
+
- lib/pharmaobservatory/models/ownership_observations_response.rb
|
|
834
|
+
- lib/pharmaobservatory/models/ownership_observations_row.rb
|
|
686
835
|
- lib/pharmaobservatory/models/ownership_percentages_response.rb
|
|
687
836
|
- lib/pharmaobservatory/models/ownership_percentages_row.rb
|
|
688
837
|
- lib/pharmaobservatory/models/ownership_positions_response.rb
|
|
689
838
|
- lib/pharmaobservatory/models/ownership_positions_row.rb
|
|
839
|
+
- lib/pharmaobservatory/models/ownership_source_coverage_response.rb
|
|
840
|
+
- lib/pharmaobservatory/models/ownership_source_coverage_row.rb
|
|
690
841
|
- lib/pharmaobservatory/models/pdufa_dates_response.rb
|
|
691
842
|
- lib/pharmaobservatory/models/pdufa_dates_row.rb
|
|
692
843
|
- lib/pharmaobservatory/models/program_licensing_candidates_response.rb
|
|
@@ -734,8 +885,23 @@ files:
|
|
|
734
885
|
- lib/pharmaobservatory/models/recalls_response.rb
|
|
735
886
|
- lib/pharmaobservatory/models/recalls_row.rb
|
|
736
887
|
- lib/pharmaobservatory/models/result_page.rb
|
|
888
|
+
- lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb
|
|
889
|
+
- lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb
|
|
890
|
+
- lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb
|
|
891
|
+
- lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb
|
|
892
|
+
- lib/pharmaobservatory/models/rwd_conductor_studies_response.rb
|
|
893
|
+
- lib/pharmaobservatory/models/rwd_conductor_studies_row.rb
|
|
894
|
+
- lib/pharmaobservatory/models/rwd_conductors_record.rb
|
|
895
|
+
- lib/pharmaobservatory/models/rwd_conductors_response.rb
|
|
896
|
+
- lib/pharmaobservatory/models/rwd_conductors_row.rb
|
|
737
897
|
- lib/pharmaobservatory/models/rwd_coverage_response.rb
|
|
738
898
|
- lib/pharmaobservatory/models/rwd_coverage_row.rb
|
|
899
|
+
- lib/pharmaobservatory/models/rwd_institutions_record.rb
|
|
900
|
+
- lib/pharmaobservatory/models/rwd_institutions_response.rb
|
|
901
|
+
- lib/pharmaobservatory/models/rwd_institutions_row.rb
|
|
902
|
+
- lib/pharmaobservatory/models/rwd_networks_record.rb
|
|
903
|
+
- lib/pharmaobservatory/models/rwd_networks_response.rb
|
|
904
|
+
- lib/pharmaobservatory/models/rwd_networks_row.rb
|
|
739
905
|
- lib/pharmaobservatory/models/rwd_register_provenance_response.rb
|
|
740
906
|
- lib/pharmaobservatory/models/rwd_register_provenance_row.rb
|
|
741
907
|
- lib/pharmaobservatory/models/rwd_registers_record.rb
|
|
@@ -767,6 +933,8 @@ files:
|
|
|
767
933
|
- lib/pharmaobservatory/models/rwd_study_milestones_row.rb
|
|
768
934
|
- lib/pharmaobservatory/models/rwd_withheld_fields_response.rb
|
|
769
935
|
- lib/pharmaobservatory/models/rwd_withheld_fields_row.rb
|
|
936
|
+
- lib/pharmaobservatory/models/sbti_crosscheck_response.rb
|
|
937
|
+
- lib/pharmaobservatory/models/sbti_crosscheck_row.rb
|
|
770
938
|
- lib/pharmaobservatory/models/sec_pdufa_dates_response.rb
|
|
771
939
|
- lib/pharmaobservatory/models/sec_pdufa_dates_row.rb
|
|
772
940
|
- lib/pharmaobservatory/models/site_beds_yearly_response.rb
|
|
@@ -787,10 +955,20 @@ files:
|
|
|
787
955
|
- lib/pharmaobservatory/models/sites_record_attributes.rb
|
|
788
956
|
- lib/pharmaobservatory/models/sites_response.rb
|
|
789
957
|
- lib/pharmaobservatory/models/sites_row.rb
|
|
958
|
+
- lib/pharmaobservatory/models/sponsor_delivery_response.rb
|
|
959
|
+
- lib/pharmaobservatory/models/sponsor_delivery_row.rb
|
|
960
|
+
- lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb
|
|
961
|
+
- lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb
|
|
962
|
+
- lib/pharmaobservatory/models/sponsor_publications_response.rb
|
|
963
|
+
- lib/pharmaobservatory/models/sponsor_publications_row.rb
|
|
790
964
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb
|
|
791
965
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb
|
|
792
966
|
- lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb
|
|
793
967
|
- lib/pharmaobservatory/models/sponsor_recruitment_duration_row.rb
|
|
968
|
+
- lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb
|
|
969
|
+
- lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb
|
|
970
|
+
- lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb
|
|
971
|
+
- lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb
|
|
794
972
|
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb
|
|
795
973
|
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb
|
|
796
974
|
- lib/pharmaobservatory/models/sponsor_trials_response.rb
|
|
@@ -812,6 +990,8 @@ files:
|
|
|
812
990
|
- lib/pharmaobservatory/models/target_drugs_row.rb
|
|
813
991
|
- lib/pharmaobservatory/models/target_evidence_response.rb
|
|
814
992
|
- lib/pharmaobservatory/models/target_evidence_row.rb
|
|
993
|
+
- lib/pharmaobservatory/models/target_investigators_response.rb
|
|
994
|
+
- lib/pharmaobservatory/models/target_investigators_row.rb
|
|
815
995
|
- lib/pharmaobservatory/models/target_patent_mentions_response.rb
|
|
816
996
|
- lib/pharmaobservatory/models/target_patent_mentions_row.rb
|
|
817
997
|
- lib/pharmaobservatory/models/target_programs_response.rb
|